UK shares opened positively Monday, with the FTSE 100 up 0.2% as investors brace for pivotal employment and inflation data this week. Market attention focuses on the Bank of England’s potential interest rate adjustments, influenced by economic indicators that could redefine monetary policy. Germany’s DAX and France’s CAC 40 mirrored cautious optimism, remaining flat and rising 0.3%, respectively.

SkinBioTherapeutics PLC (LON:SBTX) shares dropped 37% after allegations of financial misrepresentation prompted a 17% revenue reduction. The UK biotech firm faces a £770,000 royalty income reversal, widening operating losses and falling short of market forecasts. CEO Stuart Ashman’s involvement in the controversy has triggered investor panic, casting doubt on fiscal 2026 projections. Analysts warn the scandal may trigger broader sector repercussions.

Optima Health PLC (LON:OPT) secured a £100 million acquisition of PAM Healthcare, funded by £70 million in HSBC/Barclays debt and a £30 million bridge loan. Meanwhile, RBC Capital downgraded Schroders PLC (LON:SDR) to "sector perform," citing limited upside despite Nuveen’s 612p-per-share bid. The brokerage raised its price target to 610p, factoring in the takeover proposal’s cash consideration.

UK housing prices stabilized in February after a January surge, with average asking prices dipping £12 to £368,019. Despite the slowdown, annual growth remains robust at 2.8% year-on-year. Separately, the government debates accelerating defense spending to 3% of GDP, potentially reshaping fiscal priorities ahead of the 2029 election.